C71T
CANCELLED SECTION 71
24/04/2026
Voltar para busca
Dado oficial do USPTO
UROVANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
62
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
05/06/2018
Data de registro
08/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH
Examinador
GILLES, DEBORAH LYNN MEINERS
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Urovant Sciences GmbH
Representantes
Jeffrey R. Cadwell Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services as well as research and design services relating theretotechnical research in the fields of pharmaceuticalsmedical devices and biological studies; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; provision of information relating to scientific research in the field of pharmaceutical products and biomedicine
Classe 44
Provision of health information and medical information; provision of information concerning the diagnosticprophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseasesdisorders and pathologies
Publicações
Histórico de despachos e eventos da marca no USPTO.
62 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/04/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/02/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2020
FIMP
FINAL DISPOSITION PROCESSED
03/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/07/2019
PUBO
PUBLISHED FOR OPPOSITION
23/07/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/07/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2019
ALIE
ASSIGNED TO LIE
14/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
29/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/04/2019
GNFR
FINAL REFUSAL E-MAILED
09/04/2019
CNFR
FINAL REFUSAL WRITTEN
09/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/03/2019
RFNT
REFUSAL PROCESSED BY IB
13/10/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/09/2018
RFRR
REFUSAL PROCESSED BY MPU
24/09/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/09/2018
CNRT
NON-FINAL ACTION WRITTEN
22/09/2018
DOCK
ASSIGNED TO EXAMINER
22/09/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
18/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/08/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
13/08/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UROVANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.